Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

A new treatment using special nanovesicles with linoleic acid shows promise in improving hair growth and reducing irritation for hair loss.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Both terazosin and baclofen effectively reduce pain in young men with chronic testicular pain, with no difference in their effectiveness.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Wedelolactone may help treat chronic diseases by acting as an antioxidant and affecting important proteins.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

The extract from Clitoria ternatea flowers helps human skin cells grow and promotes hair growth in mice.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Spironolactone may reduce excessive hair growth in women but its effectiveness for acne is not supported.

A new treatment using conjugated linoleic acid nanovesicles can rejuvenate hair follicles and improve hair growth in androgenic alopecia.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.